Abstract
ObjectivesThe objective of our study was to use laboratory data to describe prostate-specific antigen (PSA) testing trends for primary healthcare (PHC) services from a single province. PHC is a basic package of services offered to local communities, serving as the first point of contact within the health system. These services are offered at clinics and community health centres (CHC), the latter providing additional maternity, accident and emergency services.DesignThe retrospective descriptive study design was used.MethodsWe analysed national laboratory data between 2006 and 2016 for men ≥30 years in the Gauteng Province. We used the probabilistic matching algorithm to create first-ever PSA cohort. We used the hot-deck imputation to assign missing race group values and the district health information system facility descriptors to identify PHC testing. We reported patient numbers by calendar year, age category and race group as well as descriptive statistics. We used multivariable logistic regression to assess any association for race group and age with a PSA ≥4 µg/L.ResultsBetween 2006 and 2016, numbers of men tested increased from 1782 to 67 025, respectively, with 186 984/239 506 (78.1%) tests were from clinics. The majority of testing was for men in the 50–59 age category (31.5%) and Black Africans (86.4%). We reported a median of 0.9 µg/L that increased with age. A PSA ≥4 µg/L was reported for 11.7% of men, increasing to 35.5% for the ≥70 age category. The logistic regression reported that the adjusted odds of having a PSA ≥4 µg/L was significantly lower for Indian/Asians, multiracials and whites than for Black Africans (p value<0.0001).ConclusionsOur study has shown a marked increase in PSA testing from clinics and CHC suggestive of screening for prostate cancer. The approaches reported in this study can be extended for national data.
Funder
National Cancer Institute
Reference54 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. International Agency for Research on Cancer (IARC) . GLOBOCAN cancer fact sheets: prostate cancer. Geneva, Switzerland: International Agency for Research on Cancer (IARC), 2012. http://globocan.iarc.fr/old/FactSheets/cancers/prostate-new.asp
3. An estimate of the incidence of prostate cancer in Africa: a systematic review and meta-analysis;Adeloye;PLoS One,2016
4. National Cancer Registry . Summary statistics of cancer diagnosed histologically in South Africa in 2014. Johannesburg, South Africa: National Institute for Occupational Health (NIOH), 2014. http://www.nicd.ac.za/wp-content/uploads/2017/03/2014-NCR-tables-1.pdf
5. European Association of Urology . Guidelines on prostate cancer. Aarnheim, Netherlands: European Association of Urology, 2016. https://uroweb.org/wp-content/uploads/EAU-Guidelines-Prostate-Cancer-2016.pdf
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献